Test Price
1,200 AED✅ Home Collection Available
CALR Mutation Analysis (Exon 9) – 1200 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (available daily 8 AM – 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Interpretation support by a DHA-licensed consultant medical geneticist.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
CALR exon 9 mutation analysis by Sanger sequencing confirms the presence of driver mutations in essential thrombocythemia and primary myelofibrosis, guiding risk stratification and treatment planning. This gold-standard method delivers >99.9% sensitivity for insertions and deletions in exon 9, providing rapid, cost-effective results compared to broader NGS panels.
| Feature | Our Test (Sanger Sequencing) | Closest Alternative (NGS Panel) |
|---|---|---|
| Methodology | Sanger Sequencing (gold standard for exon 9 indels) | Next‑Generation Sequencing (broad gene panel) |
| Diagnostic Sensitivity | >99.9% for exon 9 insertions/deletions | >99% but may miss small indels in low‑coverage regions |
| Turnaround Time | 7–8 working days | 14–21 working days |
| Cost | 1200 AED | 3000+ AED |
| DHA Compliance | ✓ ISO 9001:2015, DHA License 1143 | ✓ May be DHA‑registered but not exon‑specific |
Physician Insight & Safety Protocols
"As a consultant medical geneticist, I understand that waiting for genetic test results can be stressful. Our team ensures every CALR mutation report is correlated with blood counts and clinical history, and telephonic guidance is provided to help interpret the findings with your treating physician."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID 9294403
Advisory: Medication & Follow-up
Important Safety Notice
Do not discontinue prescribed medication without consulting your doctor. Genetic test results should be interpreted within the full clinical context by a qualified specialist.
Exclusion Criteria & Emergency Red Flags
Patient Safety & Exclusion Criteria
- Severe coagulopathy (e.g., hemophilia, therapeutic anticoagulation) requires physician clearance before blood draw.
- Active infection at the venipuncture site or known allergy to antiseptic solutions.
🚨 Emergency Red Flags After Sample Collection
- Persistent bleeding or large hematoma at the puncture site.
- Severe injection‑site pain, swelling, or pus discharge.
- Dizziness, fever, or chills within 24 hours.
If you experience any of these symptoms, contact +971 54 548 8731 immediately or visit your nearest emergency department.
Patient FAQ & Clinical Guidance
1. What is the CALR mutation test used for?
The CALR exon 9 mutation test identifies acquired genetic changes that drive essential thrombocythemia and primary myelofibrosis, aiding accurate diagnosis and risk stratification.
2. Do I need a doctor’s prescription for this test?
Yes, a valid UAE-licensed physician prescription is required. Pre-surgical, prenatal, or travel clearance assessments may have different requirements.
3. How is the sample collected and is it painful?
A blood sample from an arm vein is used. Discomfort is minimal and comparable to routine blood tests. Our phlebotomists are trained for a gentle experience.
UAE Regulatory & Data Privacy Adherence
Compliance Framework & Accreditation
This service strictly complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL), Federal Law No. 2 of 2019 Concerning the Use of ICT in Health Fields, and Federal Decree-Law No. 4 of 2016 on Medical Liability. All molecular testing is performed under ISO 9001:2015 Quality Management System (Cert: INT/EGQ/2509DA/3139), in a DHA-licensed facility.
Home collection service operates from 8 AM to 11 PM, 7 days a week. For appointments or insurance queries, message us on WhatsApp at +971 54 548 8731.
Clinical & Logistical Metadata
| Test Name | CALR Mutation Analysis (Exon 9) |
| Price (AED) | 1200 AED |
| Turnaround Time | 7–8 working days |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA) |
| Methodology Used | Sanger Sequencing (Gold Standard for Exon 9 Indels) |
| ICD-10-CM Code | D47.3, D47.1 |
| LOINC Code | 94758-5 |
| DHA Facility License & Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians